Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
about
Isolation and characterization of antimicrobial compounds in plant extracts against multidrug-resistant Acinetobacter baumanniiInfection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for InstitutesNecrotizing fasciitis caused by Acinetobacter baumannii : A case reportHigh and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapyIsolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumanniiApplication of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care UnitEvolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and PreventionComparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strainThe pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation.Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials.Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control programLaboratory to Clinical Investigation of Carbapenem Resistant Acinetobacter baumannii Outbreak in a General Hospital.A bronchofiberoscopy-associated outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit in Beijing, China.Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy.Investigation of pulmonary infection pathogens in neurological intensive care unit.Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne bla(OXA-72) in TaiwanInsect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans modelEffectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis.Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii.Identification of genes essential for pellicle formation in Acinetobacter baumannii.High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii.Two Multiplex Real-Time PCR Assays to Detect and Differentiate Acinetobacter baumannii and Non- baumannii Acinetobacter spp. Carrying blaNDM, blaOXA-23-Like, blaOXA-40-Like, blaOXA-51-Like, and blaOXA-58-Like Genes.5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumanniiAcinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis.Risk factors for hospital-acquired antimicrobial-resistant infection caused by Acinetobacter baumanniiCell surface hydrophobicity of colistin-susceptible vs resistant Acinetobacter baumannii determined by contact angles: methodological considerations and implicationsPrevalence of and risk factors for multidrug-resistant Acinetobacter baumannii colonization among high-risk nursing home residents.Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii.Genome sequences of two multidrug-resistant Acinetobacter baumannii strains isolated from a patient before and after treatment with tigecycline.Endemicity of Acinetobacter calcoaceticus-baumannii Complex in an Intensive Care Unit in MalaysiaGlobal metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection controlComplete genome sequence of Acinetobacter baumannii XH386 (ST208), a multi-drug resistant bacteria isolated from pediatric hospital in China.Usefulness of phenotypic and genotypic methods for metallo-beta-lactamases detection in carbapenem-resistant Acinetobacter baumannii strainsColonization pressure as a risk factor for colonization by multiresistant Acinetobacter spp and carbapenem-resistant Pseudomonas aeruginosa in an intensive care unitCarbapenem-resistant Acinetobacter ventilator-associated pneumonia: Clinical characteristics and outcomePatient Safety Walkaround: a communication tool for the reallocation of health service resources: An Italian experience of safety healthcare implementation.
P2860
Q21090766-CD2614FD-8147-4287-AB01-B0132693FDD8Q26799202-04F0C9A9-4033-4B00-9834-79F0FCFE2EFAQ28293095-FE85BA92-4796-4D13-BB29-2391E7E0C7EAQ28476377-C36C0CBB-CBCB-4756-A607-FA58591F610AQ28484243-A6DBDD2E-448A-41AE-BD88-3758B57E8113Q28555082-70E04D29-0CC8-44FB-8640-CECAF6D61EF3Q28752557-1B27728C-B06A-445B-81EF-F9AFF841BAA2Q30458327-0F4054AF-E4DC-4892-A24D-C21E09BFBDDBQ31071263-ED337ABD-8EF6-45B2-98BD-FFA77177776EQ33487075-191EE166-D9C8-4A48-B8D3-25319DB2015BQ33593516-8CA3E9AE-6715-4AA1-8C8E-3D2D2A2A6B2AQ33935406-2EC44FCF-5976-4B40-AEE7-F178EE6C3631Q34068692-EDF9D0AE-0F53-4036-895B-01609CE29706Q34496802-D6273FAA-98A3-4B63-B8F2-157570E62C87Q34541346-B0D9684D-362D-4009-95D4-70F4354F2431Q34574162-51A890AF-BE08-4361-BE5B-D8B22715CB28Q34815859-F3DE4022-1195-4ACA-B292-19B453E6A56DQ35076900-EA991AF3-C701-4001-BEE3-7747B110F340Q35101242-2647ABAB-BFC2-4F39-8618-9CD4C9728438Q35168859-E1525F5E-FD55-437C-A2F7-DFF2A6C4C8ADQ35385769-82E027CC-F36A-4782-9F1B-DC83D78447FDQ35654893-7C79399D-11AF-4F99-9022-F905CA428512Q35843094-A82AEF7E-C08E-484A-A85E-AE9587BAE5A8Q35895209-FE865F3B-3BE1-49A1-94CF-A5E94E68509EQ36071117-17C11444-F847-4023-9830-ED8EBB8A7A44Q36092494-68D4AC80-DB41-4170-9DE9-8E28E525C3EEQ36099594-82B8649C-6B41-4B93-A25B-A20330FBFD30Q36144309-90DF1FAB-FB4D-4845-ABD1-48A30E59A3ECQ36210000-6EF9BE76-CBF6-4E58-9EB2-249393FFEBCDQ36225143-767122AF-C6D3-4235-A842-49E58510E26DQ36405521-AFEBB11D-8959-4293-9980-B88CDF2340DCQ36435413-73123898-6725-4E28-A6EC-9DFAE06A94D7Q36447044-CC206B9D-0239-4F6D-A4CC-92B2CA337CC0Q36628128-7AFEFFA2-2C7A-476E-96D7-204B4D5312DAQ36638145-10E7316C-93CB-436A-8259-56BF2C1B4D7FQ36652660-9C596CC9-119D-4053-9116-0BD6E3F9BF26Q36802076-C8C4D30F-7AFF-4FE5-9218-D9C3061653AEQ37119067-3E9A66C8-8CD0-477C-9486-CBC3B9043405Q37183330-5E3A8505-1F20-497D-8F4E-BCE7EF534253Q37354755-D3EB96F9-3F21-4115-87DF-659644CC55CB
P2860
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
@en
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
@nl
type
label
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
@en
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
@nl
prefLabel
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
@en
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
@nl
P1476
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
@en
P2093
Drosos E Karageorgopoulos
P304
P356
10.1016/S1473-3099(08)70279-2
P577
2008-12-01T00:00:00Z